More on CBIO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $16.30 |
|
|||
| Open | $16.81 | ||||
| 52 Wk High | $4.57 | ||||
| 52 Wk Low | $0.62 | ||||
| Day High | $17.80 | ||||
| Day Low | $16.48 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 65,973 | ||||
- Crescent Biopharma Announces Grants of Inducement Awards
- Form SCHEDULE 13D/A CRESCENT BIOPHARMA, INC. Filed by: Fairmount Funds Management LLC
- Form 4 CRESCENT BIOPHARMA, INC. For: Jul 16 Filed by: Kiselak Tomas
- Crescent Biopharma raises $143.7M in public offering on Nasdaq
- Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- H.C. Wainwright Reiterates Neutral Rating on Crescent Biopharma Inc (CBIO)
- Form 8-K CRESCENT BIOPHARMA, INC. For: Jul 14
- Form 424B5 CRESCENT BIOPHARMA, INC.
- Crescent Biopharma prices $125M public offering of shares and warrants
- Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
Entities mentioned with CBIO
- FDA | View Related Stories »
- 13G | View Related Stories »
- 13D | View Related Stories »
- S3 | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Raymond James | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Show More...
